Currently, no. Bringing a new drug to market takes several years and a billion dollars. And I haven't seen any compelling evidence that anyone is working on a "

Currently, no. Bringing a new drug to market takes several years and a billion dollars. And I haven't seen any compelling evidence that anyone is working on a "solution". A large part of the cost and complexity is the clinical trials, of which several stages of increasing complexity are required to get FDA approval. While it might seem inefficient, it's also the reason why vaccines work so well and have such small side effects - about half of Phase 3 candidates either fail the clinical trial or are rejected by the government for some other reason. Each round of clinical trials requires significantly more money than the one before it, but it's also arguably easier to get investors on board in the later rounds as risk is lower. Smaller pharma companies often aim to get bought outright before their product is brought to market because it makes more sense for everyone involved. Maybe someone will come up with an algorithm that lets us simulate clinical trials with sufficient precision, but that seems like a far-off sci fi fantasy to me.